Company Filing History:
Years Active: 2000
Title: Philippe Maria Margaron: Innovator in Angiogenesis Inhibition
Introduction
Philippe Maria Margaron is a notable inventor based in Burnaby, Canada. He has made significant contributions to the field of medical technology, particularly in the area of angiogenesis inhibition. His innovative approach aims to improve treatment methods while ensuring the viability of underlying tissues.
Latest Patents
Margaron holds a patent for a "Model and method for angiogenesis inhibition." This invention provides a method to inhibit the formation of neovasculature while maintaining the viability of the underlying tissue. The method involves subjecting a subject in which angiogenesis is to be inhibited to sublethal photodynamic therapy. Additionally, the invention offers a model for assessing sublethal PDT protocols to inhibit angiogenesis in specific target tissues. He has 1 patent to his name.
Career Highlights
Philippe Maria Margaron is associated with QLT Inc., a company known for its advancements in medical technologies. His work at QLT Inc. has allowed him to focus on innovative solutions that address critical health challenges.
Collaborations
Margaron has collaborated with notable colleagues, including Simon Leong and Julia G Levy. These partnerships have contributed to the development and refinement of his innovative methods.
Conclusion
Philippe Maria Margaron is a distinguished inventor whose work in angiogenesis inhibition showcases his commitment to advancing medical technology. His contributions are paving the way for improved treatment options in the healthcare sector.